Linzess — Net revenues
AbbVie Linzess — Net revenues increased by 61.7% to $283M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 91.2%, from $148M to $283M. Over 4 years (FY 2021 to FY 2025), Linzess — Net revenues shows a downward trend with a -3.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong market adoption and effective commercial execution for this therapeutic, while a decrease may signal increased competition, patent expiration, or shifts in prescribing patterns.
Detailed definition
This metric represents the total net sales generated by the Linzess/Constella product line, a key gastrointestinal thera...
Peer comparison
Comparable to product-level revenue reporting for specific blockbuster drugs or therapeutic franchises within other large-cap pharmaceutical companies.
abbv_segment_linzess_constella_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $268M | $261M | $287M | $240M | $255M | $271M | $269M | $259M | $278M | $288M | $283M | $266M | $221M | $234M | $233M | $148M | $258M | $326M | $175M | $283M |
| QoQ Change | — | -2.6% | +10.0% | -16.4% | +6.3% | +6.3% | -0.7% | -3.7% | +7.3% | +3.6% | -1.7% | -6.0% | -16.9% | +5.9% | -0.4% | -36.5% | +74.3% | +26.4% | -46.3% | +61.7% |
| YoY Change | — | — | — | — | -4.9% | +3.8% | -6.3% | +7.9% | +9.0% | +6.3% | +5.2% | +2.7% | -20.5% | -18.8% | -17.7% | -44.4% | +16.7% | +39.3% | -24.9% | +91.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's linzess — net revenues?
- AbbVie (ABBV) reported linzess — net revenues of $283M in Q1 2026.
- How has AbbVie's linzess — net revenues changed year-over-year?
- AbbVie's linzess — net revenues increased by 91.2% year-over-year, from $148M to $283M.
- What is the long-term trend for AbbVie's linzess — net revenues?
- Over 4 years (2021 to 2025), AbbVie's linzess — net revenues has grown at a -3.3% compound annual growth rate (CAGR), from $1.04B to $907M.
- What does linzess — net revenues mean?
- The total net revenue generated from the sale of the Linzess/Constella pharmaceutical product line.